Details for Patent: 10,786,500

Which drugs does patent 10,786,500 protect, and when does it expire?

Patent 10,786,500 protects XOSPATA and is included in one NDA.

This patent has twenty-seven patent family members in twenty-one countries.

Summary for Patent: 10,786,500

Title:	Stable pharmaceutical composition for oral administration
Abstract:	Provided is a stable pharmaceutical composition for oral administration comprising 6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}- amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide (hereinafter referred to as compound A) or a pharmaceutically acceptable salt thereof, wherein the generation of related substances during storage is inhibited. In the stable pharmaceutical composition for oral administration, the proportion of crystals of compound A or a pharmaceutically acceptable salt thereof is 60% or more with respect to the total amount of compound A or a pharmaceutically acceptable salt thereof.
Inventor(s):	Miyazaki; Masakazu (Tokyo, JP), Ishiba; Ryohei (Tokyo, JP), Takaishi; Yuki (Tokyo, JP), Uejo; Fumiaki (Tokyo, JP)
Assignee:	ASTELLAS PHARMA INC. (Tokyo, JP)
Application Number:	15/741,377
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form;

Drugs Protected by US Patent 10,786,500

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Astellas	XOSPATA	gilteritinib fumarate	TABLET;ORAL	211349-001	Nov 28, 2018		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 10,786,500

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2015-134817	Jul 3, 2015

PCT Information
PCT Filed	July 01, 2016	PCT Application Number:	PCT/JP2016/069615
PCT Publication Date:	January 12, 2017	PCT Publication Number:	WO2017/006855

International Family Members for US Patent 10,786,500

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2989534
China	107847500
Denmark	3318259
European Patent Office	3318259
European Patent Office	4230208
Spain	2940306